Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Study on Risk Factors and Treatment Strategies for Deep Vein Thrombosis in Patients with Multiple Myeloma
Yifei Guo1, Lixiang Yan1, Xi Yang1
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300380, People's Republic of China.
Abstract:
Multiple myeloma (MM) is a malignant tumor originating from plasma cells, and in recent years, its incidence has shown a significant upward trend in our country. Venous thromboembolism (VTE) is a relatively common complication in multiple myeloma (MM) patients. Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism (PE), with patients facing a high risk of DVT during treatment. Studies have shown that the procoagulant state of MM, inflammatory response, and the therapeutic drugs used significantly increase the incidence of DVT. However, the exact mechanisms behind the increased risk of venous thrombosis are not yet fully understood. The occurrence of DVT not only has a severely negative impact on patient survival rates but also leads to adjustments in treatment plans and a reduction in patients' quality of life. This article analyzes the relationship between risk factors for DVT and MM, exploring current diagnostic methods, risk assessment tools, and personalized preventive treatment strategies, ultimately proposing future research directions. Through a review and analysis of relevant literature, it aims to enhance the understanding of multiple myeloma and deep vein thrombosis, providing references for clinical diagnosis and treatment.
Insights
Multiple myeloma (MM) patients face a high risk of deep vein thrombosis (DVT) due to the disease and its treatments. Understanding risk factors and prevention is crucial for improving patient outcomes and quality of life.
Area of Science:
- Hematology
- Oncology
- Vascular Medicine
Background:
- Multiple myeloma (MM) is a plasma cell malignancy with increasing incidence.
- Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication in MM patients.
- The procoagulant state, inflammation, and therapies in MM contribute to elevated DVT risk, though mechanisms require further elucidation.
Purpose of the Study:
- To analyze the relationship between risk factors for DVT and MM.
- To explore current diagnostic methods and risk assessment tools for DVT in MM.
- To review personalized preventive treatment strategies and propose future research directions.
Main Methods:
- Literature review and analysis of relevant studies.
- Examination of the interplay between MM pathophysiology and thrombogenesis.
- Assessment of diagnostic and therapeutic approaches for DVT in MM.
Main Results:
- MM, inflammation, and treatments significantly increase DVT incidence.
- DVT negatively impacts survival, necessitates treatment changes, and reduces quality of life.
- Current understanding of exact mechanisms linking MM and DVT requires further investigation.
Conclusions:
- Enhanced understanding of MM and DVT is vital for clinical practice.
- Personalized prevention and management strategies are essential for MM patients at risk of DVT.
- Further research is needed to fully elucidate the mechanisms and optimize DVT prevention in MM.
More Related Videos
10:26A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care